Volume 18, Number 5—May 2012
Dispatch
Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011
Table 2
Hemagglutinin-inhibition assay results, including the 6 available influenza A(H3N2)v viruses isolated in 2011, United States*
Influenza virus strain (culture method) | Titers to reference ferret antiserum |
Specimen collection date | |||||||
---|---|---|---|---|---|---|---|---|---|
PER/16 | KS/13 | WI/12 | PA/14 | MN/11 | X203 | IN/08 | IN/10 | ||
A/Perth/16/2009 (egg)† | 1,280 | <10 | <10 | <10 | 20 | 20 | <10 | <10 | 2009 Apr 7 |
A/Kansas/13/2009 (MDCK cells) | <10 | 640 | 80 | 160 | 40 | 40 | 40 | 80 | 2009 Jul 29 |
A/Wisconsin/12/2010 (MDCK cells) | <10 | 40 | 1,280 | 320 | 640 | 320 | 640 | 1,280 | 2010 Sep 10 |
A/Pennsylvania/14/2010 (egg) | <10 | 160 | 320 | 640 | 320 | 320 | 640 | 640 | 2010 Oct 26 |
A/Minnesota/11/2010 (egg) | <10 | <10 | 320 | 160 | 640 | 1,280 | 320 | 160 | 2010 Nov 26 |
A/Minnesota/11/2010 X-203 (egg)‡ | 10 | <10 | 80 | 40 | 320 | 640 | 160 | 80 | Not applicable |
A/Indiana/08/2011 (MDCK cells)* | <10 | 10 | 1,280 | 640 | 640 | 320 | 1,280 | 1,280 | 2011 Jul 24 |
A/Indiana/10/2011 (MDCK cells)* | <10 | 40 | 1,280 | 320 | 1,280 | 640 | 1,280 | 1,280 | 2011 Oct 22 |
A/Indiana/10/2011 (egg)* | <10 | 10 | 1,280 | 320 | 640 | 320 | 1,280 | 1,280 | 2011 Oct 22 |
A/Iowa/07/2011 (MDCK cells)* | <10 | 10 | 1,280 | 640 | 1,280 | 640 | 1,280 | 2,560 | 2011 Nov 14 |
A/Iowa/08/2011 (MDCK cells)* | <10 | 40 | 1,280 | 640 | 640 | 640 | 1,280 | 2,560 | 2011 Nov 14 |
A/Iowa/09/2011 (MDCK cells)* | <10 | 40 | 1,280 | 640 | 1,280 | 640 | 2560 | 2,560 | 2011 Nov 14 |
*Influenza A(H3N2)v, virus variant identified in humans, United States, 2011. Gray shading indicates antigenically similar viruses.
†Current seasonal influenza A(H3N2) vaccine virus.
‡Reassortant virus possessing the hemagglutinin and neuraminidase genes of A/Minnesota/11/2010 and the remaining 6 genes of A/PR/8/34.
Page created: April 17, 2012
Page updated: April 17, 2012
Page reviewed: April 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.